Type 1 Diabetes Trial, Recruiting (NCT05188014)

Type 1 Diabetes Trial, Recruiting NCT05188014 Sponsor: University of Alberta Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT05188014 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with type 1 diabetes for at least one year
People who have regular menstrual cycles
People who are currently taking a single-hormone type of birth control pill (called monophasic oral contraceptives)
People who live in Edmonton, Alberta and are able to travel to the University of Alberta for visits

Who may not be able to join:

People whose recent blood sugar control measure (HbA1c) is above 9.9% (confirm with trial site)
People who experience low blood sugar episodes that happen often and without warning
People who have changed the way they manage their insulin within the two months before the study
People who use an automated insulin delivery system (such as a closed-loop or artificial pancreas system)
People whose blood pressure is above 140/95
People who have a history of heart or blood vessel disease
People who have severe nerve damage in their hands or feet
People who have an active and advanced form of diabetes-related eye disease
People who take medications other than insulin that affect blood sugar levels
People who have a muscle or joint condition that would make exercise unsafe, such as a sprain, strain, or joint injury

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05188014

Sponsor: University of Alberta

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

More information: https://clinicaltrials.gov/study/NCT05188014

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with type 1 diabetes for at least one year
People who have regular menstrual cycles
People who are currently taking a single-hormone type of birth control pill (called monophasic oral contraceptives)
People who live in Edmonton, Alberta and are able to travel to the University of Alberta for visits

Who may not be able to join:

People whose recent blood sugar control measure (HbA1c) is above 9.9% (confirm with trial site)
People who experience low blood sugar episodes that happen often and without warning
People who have changed the way they manage their insulin within the two months before the study
People who use an automated insulin delivery system (such as a closed-loop or artificial pancreas system)
People whose blood pressure is above 140/95
People who have a history of heart or blood vessel disease
People who have severe nerve damage in their hands or feet
People who have an active and advanced form of diabetes-related eye disease
People who take medications other than insulin that affect blood sugar levels
People who have a muscle or joint condition that would make exercise unsafe, such as a sprain, strain, or joint injury

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Alberta

Registry

ClinicalTrials.gov

Start date

15 March 2022

Est. completion

30 June 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Blood glucose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov